Kiora Pharmaceuticals Inc (KPRX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Kiora Pharmaceuticals Inc-Aktie (KPRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	12,555% 16.00	-0.1285	0.0499	0.0451	0.0335
Operating Expenses	31.12% 2.7779	2.1186	5.9186	2.633	1.9167
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	2.7779	-	5.9685	2.6781	1.9501
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	724.08% 13.22	-2.1186	-5.9186	-2.633	-1.9167
Net Interest Income/Expense	0.223	-	0.0499	0.0451	0.0335
Nonoperating Income/Loss	487.53% 0.2311	-0.0596	0.1556	0.0192	0.0481
Income/Loss From Continuing Operations Before Tax	227.47% 16.00	-12.55	0.0499	0.0451	0.0335
Income/Loss From Continuing Operations After Tax	693.02% 13.45	-2.2686	-5.7629	-2.6138	-1.8685
Net Income/Loss	693.02% 13.45	-2.2686	-5.7629	-2.6138	-1.8685
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,802% 25.94	0.8939	7.1069	3.2898	1.8635
Diluted Average Shares	3,818% 35.03	0.8939	7.1069	3.2898	1.8635
Basic Earnings Per Share	1,200% 0.52	0.04	-0.89	-0.79	-1.00
Diluted Earnings Per Share	850.00% 0.38	0.04	-0.89	-0.79	-1.00
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%